Geode Capital Management’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.5M | Buy |
1,294,958
+92,149
| +8% | +$2.17M | ﹤0.01% | 1720 |
|
|
2025
Q1 | $28.9M | Buy |
1,202,809
+49,484
| +4% | +$1.19M | ﹤0.01% | 1691 |
|
|
2024
Q4 | $48.8M | Buy |
1,153,325
+148,660
| +15% | +$6.29M | ﹤0.01% | 1452 |
|
|
2024
Q3 | $44.4M | Buy |
1,004,665
+20,223
| +2% | +$894K | ﹤0.01% | 1496 |
|
|
2024
Q2 | $35.6M | Buy |
984,442
+23,133
| +2% | +$837K | ﹤0.01% | 1589 |
|
|
2024
Q1 | $41.5M | Buy |
961,309
+178,593
| +23% | +$7.7M | ﹤0.01% | 1487 |
|
|
2023
Q4 | $12M | Buy |
782,716
+44,149
| +6% | +$679K | ﹤0.01% | 2232 |
|
|
2023
Q3 | $10.1M | Buy |
738,567
+87,875
| +14% | +$1.2M | ﹤0.01% | 2261 |
|
|
2023
Q2 | $10.4M | Buy |
650,692
+170,647
| +36% | +$2.74M | ﹤0.01% | 2262 |
|
|
2023
Q1 | $3.73M | Buy |
480,045
+222,979
| +87% | +$1.73M | ﹤0.01% | 2764 |
|
|
2022
Q4 | $4.97M | Buy |
257,066
+17,266
| +7% | +$334K | ﹤0.01% | 2671 |
|
|
2022
Q3 | $5.11M | Buy |
239,800
+35,212
| +17% | +$750K | ﹤0.01% | 2666 |
|
|
2022
Q2 | $2.78M | Buy |
204,588
+2,041
| +1% | +$27.8K | ﹤0.01% | 2999 |
|
|
2022
Q1 | $4.76M | Buy |
202,547
+80,965
| +67% | +$1.9M | ﹤0.01% | 2823 |
|
|
2021
Q4 | $3.25M | Buy |
121,582
+49,974
| +70% | +$1.34M | ﹤0.01% | 3130 |
|
|
2021
Q3 | $1.24M | Buy |
71,608
+55,532
| +345% | +$963K | ﹤0.01% | 3571 |
|
|
2021
Q2 | $213K | Buy |
+16,076
| New | +$213K | ﹤0.01% | 4320 |
|